Get started
Author

S N Narasingan

Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV
2024 · Raman Puri, Manish Bansal, et al. · Journal of clinical lipidology · 67
PDF
Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1.
2016 · Raman Puri, Vimal Mehta, et al. · PubMed · 67
Lipid association of India expert consensus statement on management of dyslipidemia in Indians 2016 - part 1
2016 · Raman Puri, SS Iyengar, et al. · Journal of the Practice of Cardiovascular Sciences · 42
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India
2022 · Raman Puri, Vimal Mehta, et al. · Journal of clinical lipidology · 26
Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India
2022 · Raman Puri, Vimal Mehta, et al. · Journal of clinical lipidology · 22
Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1 - Executive summary
2016 · Raman Puri, ShamannaS Iyengar, et al. · Journal of Clinical and Preventive Cardiology · 21
InSH Consensus Guideline for the Management of Hypertension, 2023
2023 · Rajeev Gupta, Anuj Maheshwari, et al. · Hypertension Journal · 13
PDF
Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases
2021 · Yusuke Ohya, Kazuomi Kario, et al. · Hypertension Research · 12
PDF
Unmet Need for Further LDL-C Lowering in India despite Statin Therapy: Lipid Association of India Recommendations for the Use of Bempedoic Acid
2022 · Vimal Mehta, Raman Puri, et al. · Journal of the Association of Physicians of India · 11
PDF
Lipoprotein(a) and ASCVD risk.
2020 · Raman Puri, Vimal Mehta, et al. · PubMed · 9
Non-HDL Cholesterol and Atherosclerotic Cardiovascular Disease.
2020 · Raman Puri, Vimal Mehta, et al. · PubMed · 8
Low Density Lipoprotein Cholesterol Targets in Secondary Prevention of Atherosclerotic Cardiovascular Disease.
2020 · Raman Puri, Vimal Mehta, et al. · PubMed · 7
Apolipoprotein B as a Predictor of CVD.
2020 · Raman Puri, Vimal Mehta, et al. · PubMed · 4
Lifestyle Modification in the Prevention of Atherosclerotic Cardiovascular Disease.
2020 · Raman Puri, Vimal Mehta, et al. · PubMed · 4
Triglycerides and Atherosclerotic Cardiovascular Disease.
2020 · Raman Puri, Vimal Mehta, et al. · PubMed · 4
Presence of elevated non-HDL among patients with T2DM with CV events despite of optimal LDL-C – A report from South India
2016 · Satyavani Kumpatla, Anju Soni, et al. · Indian Heart Journal · 4
PDF
Association of Physicians of India: Position Statement on Role of Chirally Pure Molecules in Clinical Practice.
2017 · Milind Y Nadkar, Mangesh Tiwaskar, et al. · PubMed · 3
High Sensitivity C-Reactive Protein.
2020 · Raman Puri, Vimal Mehta, et al. · PubMed · 1
Appropriate use of PCSK9 Inhibitors in India.
2019 · S S Iyengar, Manish Bansal, et al. · PubMed · 1
Cystic fibrosis in one family.
1993 · S N Narasingan, T Ramachandran, et al. · PubMed · 1
Indian Society of Hypertension (InSH) Consensus Guideline for the Management of Hypertension, 2025
2025 · Rajeev Gupta, Anuj Maheshwari, et al. · Hypertension Journal
PDF
Consensus on Olmesartan in Hypertension Management: Clinical Benefits and Expert Insights From India
2025 · Puneet Saxena, Anuj Maheshwari, et al. · Journal of Hypertension
Statin Dose for Primary Cardiovascular Disease Prevention. [REFLECT Study]
2024 · Saumitra Ray, Jagdish Hiremath, et al. · Indian Heart Journal
Hypertension Outcome Trials: How Relevant are they in the Real World Practice of Medicine?
2018 · S. N. Narasingan · Hypertension Journal
From the Desk of Editor
2018 · S. N. Narasingan · Hypertension Journal
Works count: 25
Citation count: 327
H-index: 9
I10-index: 9
Year
Topic
Type